Prestige BioPharma Limited (KRX: 950210)
South Korea
· Delayed Price · Currency is KRW
14,700
-340 (-2.26%)
Dec 20, 2024, 10:52 AM KST
Prestige BioPharma Revenue
Prestige BioPharma had revenue of 2.22B KRW in the quarter ending September 30, 2024, with 3,199.98% growth. This brings the company's revenue in the last twelve months to 2.84B, up 1,140.77% year-over-year. In the fiscal year ending June 30, 2024, Prestige BioPharma had annual revenue of 689.08M with 325.77% growth.
Revenue (ttm)
2.84B
Revenue Growth
+1,140.77%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
173.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 689.08M | 527.23M | 325.77% |
Jun 30, 2023 | 161.84M | - | - |
Jun 30, 2022 | - | - | - |
Jun 30, 2021 | - | - | - |
Jun 30, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition